Resonance HealthASX:RHT +4.55% EV-to-FCF is -152.33 as of Jun. 24, 2026. The stock has 6 warning signs investors should review. Among 410 Healthcare Providers & Services companies, Resonance Health ranks worse than 243902.2% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Resonance Health's Enterprise Value is A$23.31 Mil.
Resonance Health's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was A$-0.15 Mil. Therefore, Resonance Health's EV-to-FCF for today is -152.33.
The historical rank and industry rank for Resonance Health's EV-to-FCF or its related term are showing as below:
ASX:RHT'
s EV-to-FCF Range Over the Past 10 Years
Min: -312.36 Med: -4.52 Max: 152.81
Current: -158.57
During the past 13 years, the highest EV-to-FCF of Resonance Health was 152.81. The lowest was -312.36. And the median was -4.52.
ASX:RHT's EV-to-FCF is ranked worse than 100% of 410
companies
in the Healthcare Providers & Services industry
Industry Median: 17.47
vs ASX:RHT: -158.57
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Resonance Health's PE Ratio (TTM) for today is calculated as:
Resonance Health's share price for today is A$0.046.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Resonance Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was A$0.001.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Resonance Health EV-to-FCF Related Terms
Resonance Health EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Resonance Health's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Resonance Health's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Resonance Health EV-to-FCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Resonance Health's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Resonance Health's EV-to-FCF falls into.
Resonance Health's current Enterprise Value is A$23.31 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Resonance Health's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was A$-0.15 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Resonance Health (ASX:RHT) has a EV-to-FCF of -152.33 as of Jun. 24, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Resonance Health and its competitors. According to the industry distribution chart, Resonance Health ranks #999999 out of 410 companies in the Healthcare Providers & Services industry.
Is Resonance Health's EV-to-FCF too high?
Resonance Health's current EV-to-FCF is -152.33. Based on the distribution chart, Resonance Health ranks #999999 out of 410 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does Resonance Health's EV-to-FCF compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Resonance Health ranks #999999 out of 410 companies for EV-to-FCF. This places Resonance Health in the lower half of its industry. The industry median EV-to-FCF is 17.47. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Healthcare Providers & Services company?
The median EV-to-FCF among Healthcare Providers & Services companies is 17.47, based on 410 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Resonance Health and its competitors. For the Healthcare Providers & Services industry, the median EV-to-FCF is 17.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Resonance Health's current EV-to-FCF is -152.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Resonance Health stock overvalued right now?
Based on GuruFocus' analysis, Resonance Health (ASX:RHT) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.12, compared to a current price of A$0.05 — trading 61.7% below its estimated fair value. The current EV-to-FCF is -152.33. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Resonance Health (ASX:RHT), the current EV-to-FCF is -152.33 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Resonance Health Ltd is engaged in the development and commercialisation of software-as-medical-device (SaMD) technologies and services for the quantitative analysis of radiological images in a regulated and quality-controlled environment. The Group's core SaMD product is FerriScan, a non-invasive liver analysis technology used for the assessment of iron in the liver. The Company also has several AI-assisted SaMDs including FerriSmart, HepaFatSmart, and LiverSmart. Its business segments are; SaMD1 which derives key revenue, Corporate, TrialsWest, and Resonance Clinica. Geographically, it generates maximum revenue from the Asia Pacific region and the rest from North America, and Europe, Middle East and Africa (EMEA) regions.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:RHT has been successfully added to your 